207_Combined course Presentations
DAHANCA19: Late morbidity
No significant difference
zalutumumab
Control
Eriksen, ICHNO 2015
Made with FlippingBook
DAHANCA19: Late morbidity
No significant difference
zalutumumab
Control
Eriksen, ICHNO 2015
Made with FlippingBook